Tatva Chintan Pharma Chem Limited (TATVA) — Announcement | 22 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company announces investor meeting schedule with Alchemy Capital
💡 Investor Takeaway
This meeting provides direct access to management for institutional investors without revealing new material information.

Tatva Chintan Pharma Chem Limited announced its schedule for upcoming investor meetings, including a one-on-one virtual session with Alchemy Capital Management on 28 July 2026, as part of its institutional investor engagement program. The filing confirms the meeting will reference only publicly available information and prohibits discussion of any confidential or unpublished price-sensitive information, with details accessible on the company website.

📄 View Original Announcement (PDF)

About Tatva Chintan Pharma Chem Limited (TATVA)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹3,079.1 Cr P/E: 215.4

View full TATVA stock details →

📡 Get AI alerts when TATVA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TATVA — Free

📊 More TATVA filings

See all TATVA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TATVA files new disclosures

Track TATVA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TATVA — Free

Free account · 2 AI queries/day